Sustained survivin expression from OX40 costimulatory signals drives T cell clonal expansion

Immunity

Volumn 22, Issue 5, 2005, Pages 621-631

  Song, Jianxun ^a,b   So, Takanori ^a   Cheng, Mary ^a   Tang, Xiaohong ^a   Croft, Michael ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD134 ANTIGEN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; PROTEIN KINASE B; SURVIVIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOACCUMULATION; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CELLULAR IMMUNITY; CLONAL VARIATION; CONTROLLED STUDY; EFFECTOR CELL; ENZYME ACTIVATION; IN VIVO STUDY; MITOSIS; MOUSE; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; APOPTOSIS; BASE SEQUENCE; CELL CYCLE; CELL PROLIFERATION; DNA; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MICROTUBULE-ASSOCIATED PROTEINS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, OX40; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 19344374856     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2005.03.012     Document Type: Article

References (51)

1. M.L. Alegre, K.A. Frauwirth, and C.B. Thompson T-cell regulation by CD28 and CTLA-4 Nat. Rev. Immunol. 1 2001 220 228
2. D.C. Altieri Survivin and apoptosis control Adv. Cancer Res. 88 2003 31 52
3. G. Ambrosini, C. Adida, and D.C. Altieri A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma Nat. Med. 3 1997 917 921
4. L.H. Boise, A.J. Minn, P.J. Noel, C.H. June, M.A. Accavitti, T. Lindsten, and C.B. Thompson CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL Immunity 3 1995 87 98
5. M.A. Bolton, W. Lan, S.E. Powers, M.L. McCleland, J. Kuang, and P.T. Stukenberg Aurora B kinase exists in a complex with survivin and INCENP and its kinase activity is stimulated by survivin binding and phosphorylation Mol. Biol. Cell 13 2002 3064 3077
6. P.S. Costello, M. Gallagher, and D.A. Cantrell Sustained and dynamic inositol lipid metabolism inside and outside the immunological synapse Nat. Immunol. 3 2002 1082 1089
7. M. Croft Co-stimulatory members of the TNFR family: keys to effective T-cell immunity? Nat. Rev. Immunol. 3 2003 609 620
8. A.M. Dahl, C. Klein, P.G. Andres, C.A. London, M.P. Lodge, R.C. Mulligan, and A.K. Abbas Expression of bcl-X(L) restores cell survival, but not proliferation or effector differentiation, in CD28-deficient T lymphocytes J. Exp. Med. 191 2000 2031 2038
9. S.R. Datta, H. Dudek, X. Tao, S. Masters, H. Fu, Y. Gotoh, and M.E. Greenberg Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery Cell 91 1997 231 241
10. P.F. Dijkers, K.U. Birkenkamp, E.W. Lam, N.S. Thomas, J.W. Lammers, L. Koenderman, and P.J. Coffer FKHR-L1 can act as a critical effector of cell death induced by cytokine withdrawal: protein kinase B-enhanced cell survival through maintenance of mitochondrial integrity J. Cell Biol. 156 2002 531 542
11. M. Fornaro, J. Plescia, S. Chheang, G. Tallini, Y.M. Zhu, M. King, D.C. Altieri, and L.R. Languino Fibronectin protects prostate cancer cells from tumor necrosis factor-alpha-induced apoptosis via the AKT/survivin pathway J. Biol. Chem. 278 2003 50402 50411
12. K.A. Frauwirth, J.L. Riley, M.H. Harris, R.V. Parry, J.C. Rathmell, D.R. Plas, R.L. Elstrom, C.H. June, and C.B. Thompson The CD28 signaling pathway regulates glucose metabolism Immunity 16 2002 769 777
13. S. Fukuda, and L.M. Pelus Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34(+) cells by hematopoietic growth factors: implication of survivin expression in normal hematopoiesis Blood 98 2001 2091 2100
14. A.V. Gett, F. Sallusto, A. Lanzavecchia, and J. Geginat T cell fitness determined by signal strength Nat. Immunol. 4 2003 355 360
15. I. Gramaglia, A.D. Weinberg, M. Lemon, and M. Croft Ox-40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses J. Immunol. 161 1998 6510 6517
16. J.M. Grayson, A.J. Zajac, J.D. Altman, and R. Ahmed Cutting edge: increased expression of Bcl-2 in antigen-specific memory CD8+ T cells J. Immunol. 164 2000 3950 3954
17. D. Grossman, P.J. Kim, J.S. Schechner, and D.C. Altieri Inhibition of melanoma tumor growth in vivo by survivin targeting Proc. Natl. Acad. Sci. USA 98 2001 635 640
18. J. Harriague, and G. Bismuth Imaging antigen-induced PI3K activation in T cells Nat. Immunol. 3 2002 1090 1096
19. J.B. Huppa, M. Gleimer, C. Sumen, and M.M. Davis Continuous T cell receptor signaling required for synapse maintenance and full effector potential Nat. Immunol. 4 2003 749 755
20. G. Iezzi, K. Karjalainen, and A. Lanzavecchia The duration of antigenic stimulation determines the fate of naive and effector T cells Immunity 8 1998 89 95
21. R.G. Jones, M. Parsons, M. Bonnard, V.S. Chan, W.C. Yeh, J.R. Woodgett, and P.S. Ohashi Protein kinase B regulates T lymphocyte survival, nuclear factor kappaB activation, and Bcl-X(L) levels in vivo J. Exp. Med. 191 2000 1721 1734
22. R.G. Jones, A.R. Elford, M.J. Parsons, L. Wu, C.M. Krawczyk, W.C. Yeh, R. Hakem, R. Rottapel, J.R. Woodgett, and P.S. Ohashi CD28-dependent activation of protein kinase B/Akt blocks Fas-mediated apoptosis by reventing death-inducing signaling complex assembly J. Exp. Med. 196 2002 335 348
23. L.P. Kane, P.G. Andres, K.C. Howland, A.K. Abbas, and A. Weiss Akt provides the CD28 costimulatory signal for up-regulation of IL-2 and IFN-gamma but not TH2 cytokines Nat. Immunol. 2 2001 37 44
24. K. Kobayashi, M. Hatano, M. Otaki, T. Ogasawara, and T. Tokuhisa Expression of a murine homologue of the inhibitor of apoptosis protein is related to cell proliferation Proc. Natl. Acad. Sci. USA 96 1999 1457 1462
25. M. Kornacker, M.R. Verneris, B. Kornacker, C. Scheffold, and R.S. Negrin Survivin expression correlates with apoptosis resistance after lymphocyte activation and is found preferentially in memory T cells Immunol. Lett. 76 2001 169 173
26. F. Li, G. Ambrosini, E.Y. Chu, J. Plescia, S. Tognin, P.C. Marchisio, and D.C. Altieri Control of apoptosis and mitotic spindle checkpoint by survivin Nature 396 1998 580 584
27. F. Li, E.J. Ackermann, C.F. Bennett, A.L. Rothermel, J. Plescia, S. Tognin, A. Villa, P.C. Marchisio, and D.C. Altieri Pleiotropic cell-division defects and apoptosis induced by interference with survivin function Nat. Cell Biol. 1 1999 461 466
28. D.S. O'Connor, D. Grossman, J. Plescia, F. Li, H. Zhang, A. Villa, S. Tognin, P.C. Marchisio, and D.C. Altieri Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin Proc. Natl. Acad. Sci. USA 97 2000 13103 13107
29. H. Ohashi, H. Takagi, H. Oh, K. Suzuma, I. Suzuma, N. Miyamoto, A. Uemura, D. Watanabe, T. Murakami, and T. Sugaya Phosphatidylinositol 3-kinase/Akt regulates angiotensin II-induced inhibition of apoptosis in microvascular endothelial cells by governing survivin expression and suppression of caspase-3 activity Circ. Res. 94 2004 785 793
30. Y. Ohshima, Y. Tanaka, H. Tozawa, Y. Takahashi, C. Maliszewski, and G. Delespesse Expression and function of OX40 ligand on human dendritic cells J. Immunol. 159 1997 3838 3848
31. H. Okada, C. Bakal, A. Shahinian, A. Elia, A. Wakeham, W.K. Suh, G.S. Duncan, M. Ciofani, R. Rottapel, J.C. Zuniga-Pflucker, and T.W. Mak Survivin loss in thymocytes triggers p53-mediated growth arrest and p53-independent cell death J. Exp. Med. 199 2004 399 410
32. R.V. Parry, K. Reif, G. Smith, D.M. Sansom, B.A. Hemmings, and S.G. Ward Ligation of the T cell co-stimulatory receptor CD28 activates the serine-threonine protein kinase protein kinase B Eur. J. Immunol. 27 1997 2495 2501
33. D.R. Plas, S. Talapatra, A.L. Edinger, J.C. Rathmell, and C.B. Thompson Akt and Bcl-xL promote growth factor-independent survival through distinct effects on mitochondrial physiology J. Biol. Chem. 276 2001 12041 12048
34. S. Pugazhenthi, A. Nesterova, C. Sable, K.A. Heidenreich, L.M. Boxer, L.E. Heasley, and J.E. Reusch Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein J. Biol. Chem. 275 2000 10761 10766
35. L.G. Radvanyi, Y. Shi, H. Vaziri, A. Sharma, R. Dhala, G.B. Mills, and R.G. Miller CD28 costimulation inhibits TCR-induced apoptosis during a primary T cell response J. Immunol. 156 1996 1788 1798
36. J.C. Reed The Survivin saga goes in vivo J. Clin. Invest. 108 2001 965 969
37. J.C. Reed, and J.R. Bischoff BIRinging chromosomes through cell division - and survivin' the experience Cell 102 2000 545 548
38. P.R. Rogers, J. Song, I. Gramaglia, N. Killeen, and M. Croft OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells Immunity 15 2001 445 455
39. S. Salek-Ardakani, J. Song, B.S. Halteman, A.G. Jember, H. Akiba, H. Yagita, and M. Croft OX40 (CD134) controls memory T helper 2 cells that drive lung inflammation J. Exp. Med. 198 2003 315 324
40. K.S. Schluns, W.C. Kieper, S.C. Jameson, and L. Lefrancois Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo Nat. Immunol. 1 2000 426 432
41. A.H. Sharpe, and G.J. Freeman The B7-CD28 superfamily Nat. Rev. Immunol. 2 2002 116 126
42. H.K. Shon, K.J. Cho, and A.S. Chung Survivin reduces activation-induced T cell death in G1 phase Mol. Cells 16 2003 147 153
43. J. Song, S. Salek-Ardakani, P.R. Rogers, M. Cheng, L. Van Parijs, and M. Croft The costimulation-regulated duration of PKB activation controls T cell longevity Nat. Immunol. 5 2004 150 158
44. A. Suzuki, M. Hayashida, T. Ito, H. Kawano, T. Nakano, M. Miura, K. Akahane, and K. Shiraki Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16(INK4a) and Cdk2/cyclin E complex activation Oncogene 19 2000 3225 3234
45. A. Suzuki, T. Ito, H. Kawano, M. Hayashida, Y. Hayasaki, Y. Tsutomi, K. Akahane, T. Nakano, M. Miura, and K. Shiraki Survivin initiates procaspase 3/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell death Oncogene 19 2000 1346 1353
46. I. Tamm, Y. Wang, E. Sausville, D.A. Scudiero, N. Vigna, T. Oltersdorf, and J.C. Reed IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs Cancer Res. 58 1998 5315 5320
47. A.G. Uren, L. Wong, M. Pakusch, K.J. Fowler, F.J. Burrows, D.L. Vaux, and K.H. Choo Survivin and the inner centromere protein INCENP show similar cell-cycle localization and gene knockout phenotype Curr. Biol. 10 2000 1319 1328
48. M.J. van Stipdonk, E.E. Lemmens, and S.P. Schoenberger Naive CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation Nat. Immunol. 2 2001 423 429
49. L.S. Walker, A. Gulbranson-Judge, S. Flynn, T. Brocker, C. Raykundalia, M. Goodall, R. Forster, M. Lipp, and P. Lane Compromised OX40 function in CD28-deficient mice is linked with failure to develop CXC chemokine receptor 5-positive CD4 cells and germinal centers J. Exp. Med. 190 1999 1115 1122
50. N.R. Wall, D.S. O'Connor, J. Plescia, Y. Pommier, and D.C. Altieri Suppression of survivin phosphorylation on Thr34 by flavopiridol enhances tumor cell apoptosis Cancer Res. 63 2003 230 235
51. Z. Xing, E.M. Conway, C. Kang, and A. Winoto Essential role of survivin, an inhibitor of apoptosis protein, in T cell development, maturation, and homeostasis J. Exp. Med. 199 2004 69 80